Japan Tissue Engineering Company Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Japan Tissue Engineering Company Limited with three other
companies in this sector in Japan:
Trans Genic Inc
sales of 3.60 billion Japanese Yen [US$31.76 million]
of which 42%
was TGBS business),
Gene Techno Science Co Ltd
(1.06 billion Japanese Yen [US$9.35 million]
Human Metabolome Technologies Inc
(938.18 million Japanese Yen [US$8.27 million]
of which 100%
was Metabolome analysis business).
Japan Tissue Engineering Company Limited reported sales of ¥2.27 billion (US$20.03 million)
March of 2018.
increase of 6.4%
versus 2017, when the company's sales were ¥2.14 billion.
Sales at Japan Tissue Engineering Company Limited have increased during each of the previous five years
(and since 2013, sales have increased a total of 303%).